CTOs on the Move

Accolade Inc

www.accoladeinc.com

 
Conventional approaches aren't getting the job done so we've taken a whole new approach to helping individuals make more informed, confident choices. We've built a company for the sole purpose of engaging and delighting your employees and supporting them with every health benefits or healthcare question they have. We've proven that by giving employees and their families a great service and helping them get the right care that we can create more satisfied and committed employees and lower healthcare costs for employers. We've aligned our people, processes and technology to do the hard work of simplifying healthcare. We partner with large, ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Partnership HealthPlan of California

"The Partnership HealthPlan of California, ""The HealthPlan,"" began operations in May 1994, and is a public and private organization designed to provide a cost-effective health care delivery system to Medi-Cal recipients in California 's Solano, Napa, Yolo, and Sonoma Counties."

Shiseido Cosmetics America

Shiseido Cosmetics America Ltd. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Shiseido Cosmetics America Ltd. is based in New York, NY. You can find more information on Shiseido Cosmetics America Ltd. at www.sca.shiseido.com

Allied Managed Care

Allied Managed Care is a Pasadena, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MAKO Surgical Corp.

MAKO Surgical Corp. (MAKO) is a medical device company that markets its robotic arm solution and orthopedic implants for minimally invasive orthopedic knee procedures.

Wave Life Sciences

WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering exceptional treatment options for patients. Given the unique versatility of its chemistry platform, WAVE`s pipeline will span multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.